Pathstone Holdings
TMDX icon

Pathstone Holdings’s Transmedics TMDX Stock Holding History

Pathstone Holdings’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,238
Closed -$322K – 2415
2026
Q1 		$322K Sell
3,238
-3,092
-49% -$403K ﹤0.01% 1944
2025
Q4 		$770K Sell
6,330
-2,340
-27% -$294K ﹤0.01% 1555
2025
Q3 		$973K Buy
8,670
+17
+0.2% +$1.99K ﹤0.01% 1443
2025
Q2 		$1.16M Sell
8,653
-1,619
-16% -$178K ﹤0.01% 1313
2025
Q1 		$691K Sell
10,272
-6,399
-38% -$440K ﹤0.01% 1556
2024
Q4 		$1.04M Sell
16,671
-9,710
-37% -$904K ﹤0.01% 1353
2024
Q3 		$4.14M Buy
26,381
+1,231
+5% +$190K 0.02% 621
2024
Q2 		$3.79M Buy
25,150
+8,741
+53% +$1.05M 0.02% 632
2024
Q1 		$1.21M Buy
16,409
+12,522
+322% +$1.03M 0.01% 1167
2023
Q4 		$307K Buy
+3,887
New +$234K ﹤0.01% 1808

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Pathstone Holdings's TMDX Position: Q2 2026 in Review

Pathstone Holdings sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,238 shares — an estimated $322K sold.

Pathstone Holdings first reported a position in TMDX in Q4 2023 and held it in 10 quarters. The position peaked at $4.14M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Pathstone Holdings reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Pathstone Holdings sold 3,238 Transmedics shares in Q2 2026, an estimated $322K.
  • Pathstone Holdings first reported a position in Transmedics in Q4 2023 and held it in 10 quarters.
  • Pathstone Holdings's Transmedics position peaked at $4.14M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.